Surgery
Volume 146, Issue 6 , Pages 1196-1207 , December 2009

A novel HSP90 modulator with selective activity against thyroid cancers in vitro

  • Abbas Samadi, PhD

      Affiliations

    • Department of Surgery, University of Kansas Medical Center, Kansas City, KS
    • ,
  • Peter Loo, BS

      Affiliations

    • Department of Surgery, University of Kansas Medical Center, Kansas City, KS
    • ,
  • Rithwi Mukerji, MD

      Affiliations

    • Department of Surgery, University of Kansas Medical Center, Kansas City, KS
    • ,
  • Gemma O'Donnell, PhD

      Affiliations

    • Department of Medicinal Chemistry, The University of Kansas, Lawrence, KS
    • ,
  • Xiaqin Tong, MS

      Affiliations

    • Department of Medicinal Chemistry, The University of Kansas, Lawrence, KS
    • ,
  • Barbara N. Timmermann, PhD

      Affiliations

    • Department of Medicinal Chemistry, The University of Kansas, Lawrence, KS
    • ,
  • Mark S. Cohen, MD, FACS

      Affiliations

    • Department of Surgery, University of Kansas Medical Center, Kansas City, KS
    • Corresponding Author InformationReprint requests: Mark S. Cohen, MD, FACS, Vice Chairman for Research, Department of Surgery, University of Kansas Medical Center, 2035 Sutherland Institute, Mail Stop 2005, 3901Rainbow Boulevard, Kansas City, KS 66160.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Presented at the 30th Annual Meeting of the American Association of Endocrine Surgeons, Madison, Wisconsin, May 2–5, 2009.

 Supported in part by research grants from the National Institutes of Health (P20 RR016443 to B.N.T. and M.S.C.) through the University of Kansas Center for Cancer Experimental Therapeutics (CCET) National Institutes of Health Center of Biomedical Research Excellence (COBRE) Program.

PII: S0039-6060(09)00569-8

doi: 10.1016/j.surg.2009.09.028

Surgery
Volume 146, Issue 6 , Pages 1196-1207 , December 2009

Article Tools

* Image Usage & Resolution